Ocugen, Inc. filed its 10-K on Feb 28, 2022 for the period ending Dec 31, 2021. In this report its auditor, Ernst & Young LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.64 USD | -7.87% | +22.39% | +185.22% |
Mar. 26 | North American Morning Briefing : Markets Steady -2- | DJ |
Mar. 25 | Sector Update: Health Care Stocks Steady Premarket Monday | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+185.22% | 421M | |
+9.30% | 46.03B | |
+52.73% | 44.55B | |
+7.15% | 40.8B | |
-5.11% | 28.25B | |
+18.68% | 27.71B | |
-21.92% | 18.82B | |
+14.62% | 13.91B | |
+31.85% | 12.43B | |
-8.77% | 11.06B |
- Stock
- Equities
- Stock Ocugen, Inc. - Nasdaq
- News Ocugen, Inc.
- Ocugen, Inc. Auditor Raises 'Going Concern' Doubt